Advanced search
Start date
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Toll-like receptor 4 agonists adsorbed to aluminium hydroxide adjuvant attenuate ovalbumin-specific allergic airway disease: role of MyD88 adaptor molecule and interleukin-12/interferon-gamma axis

Full text
Show less -
Bortolatto, J. ; Borducchi, E. ; Rodriguez, D. ; Keller, A. C. ; Faquim-Mauro, E. [1] ; Bortoluci, K. R. ; Mucida, D. ; Gomes, E. ; Christ, A. ; Schnyder-Candrian, S. [2] ; Schnyder, B. [2] ; Ryffel, B. [2] ; Russo, M. [3]
Total Authors: 13
[1] Inst Butantan, Immunopathol Lab, Sao Paulo - Brazil
[2] CNRS, F-45071 Orleans - France
[3] Univ Sao Paulo, ICB IV, Dept Immunol, Inst Biomed Sci, BR-05508000 Sao Paulo - Brazil
Total Affiliations: 3
Document type: Journal article
Source: CLINICAL AND EXPERIMENTAL ALLERGY; v. 38, n. 10, p. 1668-1679, Oct. 2008.
Field of knowledge: Biological Sciences - Immunology
Web of Science Citations: 45

Background Epidemiological and experimental data suggest that bacterial lipopolysaccharides (LPS) can either protect from or exacerbate allergic asthma. Lipopolysaccharides trigger immune responses through toll-like receptor 4 (TLR4) that in turn activates two major signalling pathways via either MyD88 or TRIF adaptor proteins. The LPS is a pro-Type 1 T helper cells (Th1) adjuvant while aluminium hydroxide (alum) is a strong Type 2 T helper cells (Th2) adjuvant, but the effect of the mixing of both adjuvants on the development of lung allergy has not been investigated. We determined whether natural (LPS) or synthetic (ER-803022) TLR4 agonists adsorbed onto alum adjuvant affect allergen sensitization and development of airway allergic disease. To dissect LPS-induced molecular pathways, we used TLR4-, MyD88-, TRIF-, or IL-12/IFN-GAMMA-deficient mice. Mice were sensitized with subcutaneous injections of ovalbumin (OVA) with or without TLR4 agonists co-adsorbed onto alum and challenged with intranasally with OVA... (AU)

FAPESP's process: 04/14297-6 - Activation/deactivation of macrophages and CD4+ T lymphocytes in experimental asthma
Grantee:Momtchilo Russo
Support Opportunities: Research Projects - Thematic Grants